We have located links that may give you full text access.
Clinical Trial
Comparative Study
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Randomized controlled study of stroke unit care versus stroke team care in different stroke subtypes.
Stroke; a Journal of Cerebral Circulation 2002 Februrary
BACKGROUND AND PURPOSE: The benefits of stroke unit management may vary according to stroke subtype. A post hoc analysis of the influence of stroke subtype on stroke unit effectiveness was undertaken by using prospective data collected in a randomized controlled trial.
METHODS: Two hundred sixty-seven patients with moderately severe ischemic stroke (164 with large-vessel infarcts and 103 with lacunar infarcts) were randomly allocated to treatment in stroke units or in general medical wards with specialist stroke team support. Mortality, institutionalization, neurological, functional, and quality-of-life scores and resource use were assessed at 3 and again at 12 months after stroke onset. An intention-to-treat analysis was undertaken, and logistic regression was used to evaluate the independent effect of stroke unit intervention.
RESULTS: Stroke team-supported management was associated with higher mortality (odds ratio [OR] 4.9, 95% CI 1.3 to 18.6) and higher mortality or institutionalization (OR 2.9, 95% CI 1.1 to 7.4) at 3 months (OR 3.6, 95% CI 1.5 to 8.7) and at 1 year (OR 2.8, 95% CI 1.3 to 6.2) in patients with large-vessel infarcts. In contrast, there were no significant differences in outcome in patients with lacunar strokes managed in the stroke unit or by the stroke team. In patients with lacunar strokes, stroke unit care was associated with a longer length of hospital stay (18 versus 13.5 days for stroke unit care versus stroke team care, respectively; P<0.01) and significantly greater use of therapy.
CONCLUSIONS: Stroke units improve the outcome in patients with large-vessel infarcts but not in those with lacunar syndromes. For lacunar strokes, stroke unit management may be associated with higher initial health costs for equivalent benefit.
METHODS: Two hundred sixty-seven patients with moderately severe ischemic stroke (164 with large-vessel infarcts and 103 with lacunar infarcts) were randomly allocated to treatment in stroke units or in general medical wards with specialist stroke team support. Mortality, institutionalization, neurological, functional, and quality-of-life scores and resource use were assessed at 3 and again at 12 months after stroke onset. An intention-to-treat analysis was undertaken, and logistic regression was used to evaluate the independent effect of stroke unit intervention.
RESULTS: Stroke team-supported management was associated with higher mortality (odds ratio [OR] 4.9, 95% CI 1.3 to 18.6) and higher mortality or institutionalization (OR 2.9, 95% CI 1.1 to 7.4) at 3 months (OR 3.6, 95% CI 1.5 to 8.7) and at 1 year (OR 2.8, 95% CI 1.3 to 6.2) in patients with large-vessel infarcts. In contrast, there were no significant differences in outcome in patients with lacunar strokes managed in the stroke unit or by the stroke team. In patients with lacunar strokes, stroke unit care was associated with a longer length of hospital stay (18 versus 13.5 days for stroke unit care versus stroke team care, respectively; P<0.01) and significantly greater use of therapy.
CONCLUSIONS: Stroke units improve the outcome in patients with large-vessel infarcts but not in those with lacunar syndromes. For lacunar strokes, stroke unit management may be associated with higher initial health costs for equivalent benefit.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app